Showing 1 - 3 results of 3 for search 'van de Laar MAFJ', query time: 1.11s
Refine Results
-
1
-
2
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis by Van De Laar CJ, Oude Voshaar MAH, Fakhouri WKH, Zaremba-Pechmann L, De Leonardis F, De La Torre I, Van De Laar MAFJ
Published 2020-04-01
Article -
3